You have 9 free searches left this month | for more free features.

envafolimab

Showing 1 - 25 of 26

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)

Not yet recruiting
  • Immunotherapy;Envafolimab; Esophageal Cancer
  • Envafolimab
  • +2 more
  • (no location specified)
Apr 24, 2023

A Prospective, Randomized Controlled Study of Cyclophosphamide,

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Envafolimab
  • Shijiazhuang, Hebei, China
    Hebei
Aug 20, 2023

Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Envafolimab
  • +2 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 24, 2023

Locally Advanced Cervical Cancer Trial in Chongqing (Envafolimab, Cisplatin, External Beam Radiotherapy (EBRT))

Not yet recruiting
  • Locally Advanced Cervical Cancer
  • Envafolimab
  • +3 more
  • Chongqing, CHN, China
    Chongqing university Cancer Hospital
Apr 3, 2023

Neoadjuvant Envafolimab in Resectable and Locally Advanced

Not yet recruiting
  • Locally Advanced Rectal Carcinoma
  • MSI-High
  • Envafolimab
  • (no location specified)
Dec 9, 2022

Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)

Recruiting
  • Advanced Sarcoma
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Center
Dec 5, 2022

Rectal Cancer Trial in Hangzhou (Envafolimab)

Recruiting
  • Rectal Cancer
  • Envafolimab
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
May 4, 2023

Colorectal Tumors Trial (Envafolimab, recombinant human endostatin (endostatin))

Not yet recruiting
  • Colorectal Neoplasms
  • Envafolimab
  • recombinant human endostatin (endostatin)
  • (no location specified)
Sep 19, 2022

Esophageal Squamous Cell Carcinoma Trial (Envafolimab, Albumin-Bound Paclitaxel, Carboplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Envafolimab
  • +2 more
  • (no location specified)
Sep 21, 2022

Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma Trial (fruquintinib, Envafolimab)

Not yet recruiting
  • Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
  • (no location specified)
Jul 10, 2023

Gastric/Gastroesophageal Junction Adenocarcinoma, Radiotherapy, Immunotherapy Trial (Envafolimab)

Not yet recruiting
  • Gastric/Gastroesophageal Junction Adenocarcinoma
  • +2 more
  • Envafolimab
  • (no location specified)
May 18, 2022

Advanced Endometrial Cancer Trial in China (Envafolimab+Lenvatinib, Envafolimab)

Recruiting
  • Advanced Endometrial Cancer
  • Beijing, Beijing, China
  • +18 more
Jan 2, 2023

Metastatic or Recurrent Gastric Adenocarcinoma Trial in Nanjing (Envafolimab, Oxaliplatin, S1)

Recruiting
  • Metastatic or Recurrent Gastric Adenocarcinoma
  • Envafolimab
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Institute & Hospital
Apr 19, 2022

Ovarian Cancer, Epithelial Trial in Nanjing (Envafolimab, Lenvatinib, VP-16)

Not yet recruiting
  • Ovarian Cancer, Epithelial
  • Envafolimab
  • +2 more
  • Nanjing, Jiangsu, China
    Zhongda Hospital
Jun 13, 2022

NSCLC Stage III Trial in Hefei (Envafolimab)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage III
  • Envafolimab
  • Hefei, Anhui, China
    Anhui Provincial Cancer Hospital
Jun 8, 2022

Colon Cancer Trial (Envafolimab)

Not yet recruiting
  • Colon Cancer
  • Envafolimab
  • (no location specified)
Apr 13, 2022

Rectal Cancer Trial in Fuzhou (radiation, drug, procedure)

Not yet recruiting
  • Rectal Cancer
  • split-course hypofraction radiotherapy
  • +3 more
  • Fuzhou, Fujian, China
    Pan Chi
Jul 23, 2023

Advanced Pancreatic Cancer Trial in Xuzhou (Envafolimab, Endostar, Nab paclitaxel)

Not yet recruiting
  • Advanced Pancreatic Cancer
  • Envafolimab
  • +3 more
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Mar 18, 2022

Advanced Hepatocellular Carcinoma Trial in Hangzhou (Envafolimab, TACE, Lenvatinib)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Envafolimab
  • +2 more
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Mar 13, 2022

Lung Tumors Trial (Envafolimab, Endostar)

Not yet recruiting
  • Lung Neoplasms
  • (no location specified)
Feb 8, 2022

NSCLC Trial in Changsha (envafolimab)

Enrolling by invitation
  • Non-small Cell Lung Cancer
  • envafolimab
  • Changsha, Hunan, China
    the second Xiangya hospital
May 1, 2022

Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)

Recruiting
  • Colon Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Aug 26, 2023

NSCLC Stage IV Trial in Xiamen (Envafolimab)

Active, not recruiting
  • Non-small Cell Lung Cancer Stage IV
  • Envafolimab
  • Xiamen, Fujian, China
    First affiliated Hospital of Xiamen University
Sep 14, 2021

Non Small Cell Lung Cancer Trial in China (Chidamide, Envafolimab)

Recruiting
  • Non Small Cell Lung Cancer
  • Hefei, Anhui, China
  • +11 more
Jan 17, 2022

Biliary Tract Cancer Trial (RC48-ADC, Envafolimab)

Not yet recruiting
  • Biliary Tract Cancer
  • (no location specified)
Jun 9, 2022